Universal newborn hearing screening
F. Declau*, A. Doyen**, T. Robillard***, S. Janssens de Varebeke****
*Department of Otorhinolaryngology, Head & Neck Surgery and Communication Disorders, University of Antwerp; **Department of Otorhinolaryngology, Head & Neck Surgery, Clinique Notre Dame, Tournai, 3; ***Department of Otorhinolaryngology, Head & Neck Surgery, Clinique et Maternité Sainte-Elisabeth, Namur; ****Department of Otorhinolaryngology, Head & Neck Surgery, Virga Jesseziekenhuis, Hasselt
Universal hearing screening; newborns; automated auditory brainstem response; otoacoustic emissions; speech development
16 - 23
Hearing loss is one of the most common congenital anomalies, occurring in approximately 1-2 infants per 1000. Left undetected, hearing impairments in infants can negatively impact speech and language acquisition, academ- ic achievement, social and emotional development. These negative impacts can be diminished and even eliminated through early intervention at or before 6 months of age. Reliable screening tests that minimize referral rates and maxi- mize sensitivity and specificity are available. The goal of universal neonatal hearing screening is to maximize linguistic and communicative competence and literacy development for children who are hard of hearing or deaf.Audiologic and medical evaluations should be in progress before 3 months of age. Infants with confirmed hearing loss should receive intervention before 6 months of age from health care and education professionals with expertise in hearing loss and deaf- ness in infants and young children.
Suppl. 1, 2005

Universal newborn hearing screening